Isolation of lung tumor specific peptides from a random peptide library: Generation of diagnostic and cell-targeting reagents

Cancer Letters

Volumn 202, Issue 2, 2003, Pages 219-230

  Oyama, Tsuksa ^a,b   Sykes, Kathryn F ^a,b,c   Samli, Kausar N ^a,b   Minna, John D ^a,b   Johnston, Stephen Albert ^a,b   Brown, Kathlynn C ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MacroGenics Inc   (United States)

Author keywords

Cell targeting; Lung cancer; Peptide library; Peptides; Phage display

Indexed keywords

ARGINYLGLYCYLASPARTYLLEUCYLALANYLTHREONYLLEUCYLARGINYLGLUTAMYLLEUCYLALAN YLG LUTAMYLGLUTAMINYLASPARTYLGLYCYLVALYLVALYLGLYCYLVALYLARGININE; ASPARAGINYLGLUTAMYLARGINYLGLYCYLTHREONYLGLUTAMINYLLEUCYLARGINYLSERYLPROL YLS ERYLVALYLASPARTYLLEUCYLASPARAGINYLLYSYLPROLYLGLYCYLARGINYLHISTIDINE; GLUTAMINYLARGINYLPHENYLALANYLTRYPTOPHYLASPARTYLTRYPTOPHYLSERYLLEUCYLLEUC YLA LANYLISOLEUCYLGLUTAMINYLPROLYLLEUCYLTRYPTOPHYLTHREONYLLYSYLTRYPTOPHYLARGINYLALAN INE; METHIONYLTHREONYLVALYLCYSTEINYLASPARAGINYLALANYLSERYLGLUTAMYLARGINYLGLUT AMY LALANYLHISTIDYLALANYLGLUTAMYLALANYLTHREONYLALANYLVALYLSERYLLEUCINE; VALYLSERYLGLUTAMYLTHREONYLMETHIONYLARGINYLGLUTAMYLTHREONYLALANYLVALYLPRO LYL LEUCYLLEUCYLTRYPTOPHYLPHENYLALANYLTRYPTOPHYLTHREONYLGLYCYLSERYLLEUCINE; CELL RECEPTOR; LIGAND; PEPTIDE; PEPTIDE LIBRARY; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL SPECIFICITY; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN ISOLATION; RECEPTOR BINDING; TARGET CELL;

EID: 0344440985     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.08.011     Document Type: Article

References (49)

1. Nicholson S.A., Beasley M.B., Brambilla E., Hasleton P.S., Colby T.V., Sheppard M.N., Falk R., Travis W.D. Small cell lung carcinoma: a clinicalpathologic study of 100 cases with surgical specimens. Am. J. Surg. Path. 26:2002;1184-1197.
2. Sorensen J.B., Hirsch F.R., Gazdar A., Olsen J.E. Interobserver variability in histopathologic subtyping and grading of pulmonary adenocarcinoma. Cancer Lett. 71:1993;2971.
3. Stephenson J. Human genome studies expected to revolutionize cancer classification. JAMA. 282:1999;927-928.
4. Rubin B.P. Recent progress in the classification of soft tissue tumors: role of genetics and clinical implications. Curr. Opin. Onc. 13:2001;256-260.
5. Alon U., Barkai N., Notterman D.A., Gish K., Ybarra S., Mack D., Levine A.J. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Nat. Acad. Sci. USA. 96:1999;6745-6750.
6. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., Fluge O., Pergamenschikov A., Williams C., Zhu S.X., Lonning P.E., Borresen-Dale A.L., Brown P.O., Botstein D. Molecular portraits of human breast tumors. Nature. 406:2000;747-752.
7. Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P., Iyer V., Jeffrey S.S., Van de Rijn M., Waltham M., Pergamenschikov A., Lee J.C., Lashkari D., Shalon D., Myers T.G., Weinstein J.N., Botstein D., Brown P.O. Systematic variation in gene expression patterns in human cancer cell lines. Nature Gen. 24:2000;227-235.
8. Perou C.M., Jeffrey S.S., van de Rijn M., Rees C.A., Eisen M.B., Ross D.T., Pergamenschikov A., Williams C.F., Zhu S.X., Lee J.C., Lashkari D., Shalon D., Brown P.O., Botstein D. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Nat. Acad. Sci. USA. 96:1999;9212-9217.
9. Hedenfalk I., Duggan D., Chen Y., Radmacher M., Bittner M., Simon R., Meltzer P., Gusterson B., Esteller M., Kallioniemi O.P., Wilfond B., Borg A., Trent J. Gene-expression profiles in hereditary breast cancer. New Eng. J. Med. 344:2001;539-548.
10. Sugita M., Geraci M., Gao B., Powell R.L., Hirsch F.R., Johnson G., Lapadat R., Gabrielson E., Bremnes R., Bunn P.A., Franklin W.A. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Cancer Res. 62:2002;3971-3979.
11. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Thorsen T., Quist H., Matese J.C., Brown P.O., Botstein D., Eystein Lonning P., Borresen-Dale A.L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Nat. Acad. Sci. USA. 98:2001;10869-10874.
12. Zhang J., Spring H., Schwab M. Neuroblastoma tumor cell-binding peptides identified through random peptide phage display. Cancer Lett. 171:2001;153-164.
13. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., Ladd C., Beheshti J., Bueno R., Gillette M., Loda M., Weber G., Mark E.J., Lander E.S., Wong W., Johnson B.E., Golub T.R., Sugarbaker D.J., Meyerson M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Nat. Acad. Sci. USA. 98:2001;13790-13795.
14. Snijders A.M., Meijer G.A., Brakenhoff R.H., van den Brule A.J., van Diest P.J. Microarray techniques in pathology: tool or toy? Mol. Path. 53:2000;289-294.
15. King H.C., Sinha A.A. Gene expression profile analysis by DNA microarrays: promise and pitfalls. JAMA. 286:2001;2280-2288.
16. Pollack J.R., Van de Rijn M., Botstein D. Challenges in developing a molecular characterization of cancer. Sem. Onc. 29:2002;280-285.
17. Fong K.M., Minna J.D. Molecular biology of lung cancer:clinical implications. Clin. Chest Med. 23:2002;83-101.
18. Barry M.A., Dower W.J., Johnston S.A. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nature Med. 2:1996;299-305.
19. Brown K.C. New approaches for cell-specific targeting: identification of cell-selective peptides from combinatorial libraries. Curr. Opin. Chem. Biol. 4:2000;16-21.
20. Phelps R.M., Johnson B.E., Ihde D.C., Gazdar A.F., Carbone D.P., Linnoila P., Matthews M.J., Bunn P.A., Carney D., Minna J.D., Mulshine J.L. NCI-Navy medical oncology branch cell line data base. J. Cell. Biochem. 24:(Supplement):1996;32-91.
21. Cwirla S.E., Peters E.A., Barrett R.W., Dower W.J. Peptides on phage: A vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. USA. 87:1990;6378-6382.
22. Bonnycastle L.L.C., Menendez A., Scott J.K. General phage methods. Silverman G. Phage Display. A Laboratory Manual. 2000;15.11-15.30 Cold Spring Harbor Press, Cold Spring Harbor.
23. Ivanenkov V.V., Felici F., Menon A.G. Uptake and intracellular fate of phage display vectors in mammalian cells. Biochim. Biophys. Acta. 1448:1999;450-462.
24. Ivanenkov V.V., Felici F., Menon A.G. Targeted delivery of multivalent phage display vectors into mammalian cells. Biochim. Biophys. Acta. 1448:1999;463-472.
25. Tam J.P. Recent advances in multiple antigen peptides. J. Immun. Meth. 196:1996;17-32.
26. Tam J.P. Synthetic peptide vaccine design: synthesis and properties of a high density multiple antigenic system. Proc. Natl. Acad. Sci. 85:1988;5409-5413.
27. Tam J.P., Lu Y.A., Yang J.L. Antimicrobial dendrimeric peptides. Eur. J. Biochem. 269:2002;923-932.
28. Duffy M.J. Biochemical markers in breast cancer: which ones are clinically useful? Clin. Biochem. 34:2001;347-352.
29. Skirnisdottir I., Sorbe B., Seidal T. The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma. Int. J. Gyn. Cancer. 11:2001;119-129.
30. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Levin W.J., Stuart S.G., Udove J., Ullrich A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 244:1989;707-712.
31. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1:2000;31-39.
32. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:1992;11-25.
33. Koivunen E., Wang B., Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology. 13:1995;265-270.
34. Ruoslahti E. RGD and other recognition sequences for integrins. Ann. Rev. Cell Dev. Biol. 12:1996;697-715.
35. Horn S., Moersig W., Moll R., Oelert H., Lorenz J. Expression of cell adhesion molecules in lung cancer cell lines. Exp. Tox. Path. 48:1996;535-540.
36. Falcioni R., Cimino L., Gentileschi M.P., D'Agnano I., Zupi G., Kennel S.J., Sacchi A. Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypes. Exp. Cell Res. 210:1994;113-122.
37. Bartolazzi A., Cerboni C., Flamini G., Bigotti A., Lauriola L., Natali P.G. Expression of alpha 3 beta 1 integrin receptor and its ligands in human lung tumors. Int. J. Cancer. 64:1995;248-252.
38. Koukoulis G.K., Warren W.H., Virtanen I., Gould V.E. Immunolocalization of integrins in the normal lung and in pulmonary carcinomas. Human Path. 28:1997;1018-1025.
39. Damjanovich L., Albelda S.M., Mette S.A., Buck C.A. Distribution of integrin cell adhesion receptors in normal and malignant lung tissue. Am. J. Resp. Cell Mol. Biol. 6:1992;197-206.
40. Mette S.A., Pilewski J., Buck C.A., Albelda S.M. Distribution of integrin cell adhesion receptors on normal bronchial epithelial cells and lung cancer cells in vitro and in vivo. Am. J. Resp. Cell Mol. Biol. 8:1993;562-572.
41. Roussel E., Gingras M.C., Ro J.Y., Branch C., Roth J.A. Loss of alpha 1 beta 1 and reduced expression of other beta 1 integrins and CAM in lung adenocarcinoma compared with pneumocytes. J. Surg. Onc. 56:1994;198-208.
42. Patriarca C., Alfano R.M., Sonnenberg A., Graziani D., Cassani B., de Melker A., Colombo P., Languino L.R., Fornaro M., Warren W.H., Coggi G., Gould V.E. Integrin laminin receptor profile of pulmonary squamous cell and adenocarcinomas. Human Path. 29:1998;1208-1215.
43. Adachi M., Taki T., Huang C., Higashiyama M., Doi O., Tsuji T., Miyake M. Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung. J. Clin. Onc. 16:1998;1060-1067.
44. Mazzucchelli L., Burrit J.B., Jesaitis A.J., Nusrat A., Liang T.W., Gewirtz A.T., Schnell F.J., Parkos C.A. Cell-specific peptide binding by human neutrophils. Blood. 93:1999;1738-1748.
45. Rasmussen U.B., Schreiber V., Schultz H., Mischler F., Schughart K. Tumor cell-targeting by phage-displayed peptides. Cancer Gene Ther. 9:2002;606-612.
46. Kiessling L.L., Gestwicki J.E., Strong L.E. Synthetic multivalent ligands in the exploration of cell-surface interactions. Curr. Opin. Chem. Biol. 4:2000;696-703.
47. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276:2001;5836-5840.
48. Rothbard J.B., Kreider E., VanDeusen C.L., Wright L., Wylie B.L., Wender P.A. Argine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J. Med. Chem. 45:2002;3612-3618.
49. Futaki S., Nakase I., Suzuki T., Youjun Z., Sugiura Y. Translocation of branched-chain arginine peptides through cell membranes: flexibility in the spatial disposition of positive charges in membrane-permeable peptides. Biochemistry. 41:2002;7925-7930.